2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients (Q13920)
From MaRDI portal
scientific article (doi: 10.1007/s00520-024-08462-x)
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | 2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients |
scientific article (doi: 10.1007/s00520-024-08462-x) |
Statements
2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients (English)
0 references
32
0 references
5
0 references
10 April 2024
0 references
Samantha K. F. Kennedy
0 references
Shannon Goodall
0 references
Shing Fung Lee
0 references
Carlo DeAngelis
0 references
Allison Jocko
0 references
Flay Charbonneau
0 references
Katie Wang
0 references
Mark Pasetka
0 references
Yoo-Joung Ko
0 references
Henry C. Y. Wong
0 references
Adrian Wai Chan
0 references
Thenugaa Rajeswaran
0 references
Milena Gojsevic
0 references
Edward Chow
0 references
Richard J. Gralla
0 references
Terry L. Ng
0 references
Katarzyna J. Jerzak
0 references
